Table of Contents Author Guidelines Submit a Manuscript
Depression Research and Treatment
Volume 2011, Article ID 896395, 6 pages
http://dx.doi.org/10.1155/2011/896395
Research Article

Antidepressant Therapy in Severe Depression May Have Different Effects on Ego-Dystonic and Ego-Syntonic Suicidal Ideation

1Division of Psychiatry, Department of Clinical Sciences Lund, Lund University Hospital, 221 85 Lund, Sweden
2Department of Clinical Alcohol Research, University Hospital MAS, Lund University, Malmö, Sweden

Received 30 December 2010; Accepted 13 March 2011

Academic Editor: Verinder Sharma

Copyright © 2011 Louise Brådvik and Mats Berglund. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. A. Montgomery, D. L. Dunner, and G. C. Dunbar, “Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo,” European Neuropsychopharmacology, vol. 5, no. 1, pp. 5–13, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Letizia, B. Kapik, and W. D. Flanders, “Suicidal risk during controlled clinical investigations of fluvoxamine,” Journal of Clinical Psychiatry, vol. 57, no. 9, pp. 415–421, 1996. View at Google Scholar · View at Scopus
  3. J. F. Wernicke, M. E. Sayler, S. C. Koke, D. K. Pearson, and G. D. Tollefson, “Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior,” Depression and Anxiety, vol. 6, no. 1, pp. 31–39, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Avedisova, V. Borodin, K. Zakharova, and A. Aldushin, “Effect of milnacipran on suicidality in patients with mild to moderate depressive disorder,” Neuropsychiatric Disease and Treatment, vol. 5, no. 1, pp. 415–420, 2009. View at Google Scholar · View at Scopus
  5. P. Courtet, “Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran,” Neuropsychiatric Disease and Treatment, vol. 7, no. 6, pp. 3–8, 2010. View at Google Scholar
  6. D. Healy, “Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors,” Psychotherapy and Psychosomatics, vol. 72, no. 2, pp. 71–79, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Healy and C. Whitaker, “Antidepressants and suicide: risk-benefit conundrums,” Journal of Psychiatry and Neuroscience, vol. 28, no. 5, pp. 331–337, 2003. View at Google Scholar · View at Scopus
  8. C. L. Rich, D. G. Spiker, S. W. Jewell, and J. F. Neil, “Response of energy and suicidal ideation to ECT,” Journal of Clinical Psychiatry, vol. 47, no. 1, pp. 31–32, 1986. View at Google Scholar · View at Scopus
  9. C. H. Kellner, M. Fink, R. Knapp et al., “Relief of expressed suicidal intent by ECT: a consortium for research in ECT study,” American Journal of Psychiatry, vol. 162, no. 5, pp. 977–982, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Patel, S. Patel, D. W. Hardy, B. J. Benzies, and V. Tare, “Should electroconvulsive therapy be an early consideration for suicidal patients?” Journal of ECT, vol. 22, no. 2, pp. 113–115, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. M. H. Teicher, C. A. Glod, and J. O. Cole, “Antidepressant drugs and the emergence of suicidal tendencies,” Drug Safety, vol. 8, no. 3, pp. 186–212, 1993. View at Google Scholar · View at Scopus
  12. N. Perroud, R. Uher, A. Marusic et al., “Suicidal ideation during treatment of depression with escitalopram and nortriptyline in Genome-Based Therapeutic Drugs for Depression (GENDEP): a clinical trial,” BMC Medicine, vol. 7, article 1741, p. 60, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Stübner, R. Grohmann, I. von Stralendorff et al., “Suicidality as rare adverse event of antidepressant medication: report from the AMSP multicenter drug safety surveillance project,” Journal of Clinical Psychiatry, vol. 71, no. 10, pp. 1293–1307, 2010. View at Google Scholar
  14. E. Ringel, Selbstmordverhütung, Verlag Hans Huber, Stuttgart, Germany, 1969.
  15. H. S. Akiskal, “Mood Disorders,” in Kaplan & Saddock's Comprehensive Textbook of Psychiatry, B. J. Sadock and V. A. Saddock, Eds., pp. 1284–1440, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 7th edition, 2000. View at Google Scholar
  16. L. Brådvik and M. Berglund, “Suidical ideation in severe depression,” European Archives of Psychiatry and Clinical Neuroscience, vol. 250, no. 3, pp. 139–143, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Brådvik and M. Berglund, “Long-term treatment and suicidal behavior in severe depression: ECT and antidepressant pharmacotherapy may have different effects on the occurrence and seriousness of suicide attempts,” Depression and Anxiety, vol. 23, no. 1, pp. 34–41, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Brådvik and M. Berglund, “Treatment and suicide in severe depression: a case-control study of antidepressant therapy at last contact before suicide,” Journal of ECT, vol. 16, no. 4, pp. 399–408, 2000. View at Google Scholar
  19. E. Essen-Möller and S. Wohlfahrt, “Suggestion for the amendment of the official Swedish classification of mental disorders,” Psychological Medicine, vol. 1, pp. 308–311, 1947. View at Google Scholar
  20. ICD 8, International Statistical Classification of Disease, Klassifikation av Sjukdomar, Systematisk Förteckning, 1968.
  21. ICD 9, International Statistical Classification of Disease, Klassifikation av Sjukdomar, Systematisk Förteckning, 1987.
  22. ICD 10, International Statistical Classification of Disease, Klassifikation av Sjukdomar, Systematisk Förteckning, 1997.
  23. L. Bradvik and M. Berglund, “Risk factors for suicide in melancholia. A case-record evaluation of 89 suicides and their controls,” Acta Psychiatrica Scandinavica, vol. 87, no. 5, pp. 306–311, 1993. View at Google Scholar · View at Scopus
  24. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, DSM-IV, Washington, DC, USA, 4th edition, 1994.
  25. A. T. Beck, M. Kovacs, and A. Weissman, “Assessment of suicidal intention: the scale for suicide ideation,” Journal of Consulting and Clinical Psychology, vol. 47, no. 2, pp. 343–352, 1979. View at Publisher · View at Google Scholar
  26. J. O. Ottosson, Psykiatri, Almqvist & Wiksell, Uppsala, Sweden, 1983.
  27. S. S. Canetto and I. Sakinofsky, “The gender paradox in suicide,” Suicide and Life-Threatening Behavior, vol. 28, no. 1, pp. 1–23, 1998. View at Google Scholar · View at Scopus
  28. B. A. Gaudiano, C. G. Beevers, and I. W. Miller, “Differential response to combined treatment in patients with psychotic versus nonpsychotic major depression,” Journal of Nervous and Mental Disease, vol. 193, no. 9, pp. 625–628, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Reeves, S. Batra, R. S. May, R. Zhang, D. C. Dahl, and X. Li, “Efficacy of risperidone augmentation to antidepressants in the management of suicidality in major depressive disorder: a randomized, double-blind, placebo-controlled pilot study,” Journal of Clinical Psychiatry, vol. 69, no. 8, pp. 1228–1236, 2008. View at Google Scholar · View at Scopus
  30. L. Brådvik, C. Mattisson, M. Bogren, and P. Nettelbladt, “Mental disorders in suicide and undetermined death in The Lundby Study. The contribution of severe depression and alcohol dependence,” Archives of Suicide Research, vol. 14, no. 3, pp. 266–275, 2010. View at Publisher · View at Google Scholar
  31. T. Helgason, “Epidemiology of mental disorders in Iceland. A psychiatric and demographic investigation of 5395 Icelanders,” Acta psychiatrica Scandinavica, vol. 40, supplement 173, p. 258, 1964. View at Google Scholar · View at Scopus
  32. L. Brådvik, C. Mattisson, M. Bogren, and P. Nettelbladt, “Long-term suicide risk of depression in the Lundby cohort 1947–1997—severity and gender,” Acta Psychiatrica Scandinavica, vol. 117, no. 3, pp. 185–191, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Jick, J. A. Kaye, and S. S. Jick, “Antidepressants and the risk of suicidal behaviors,” Journal of the American Medical Association, vol. 292, no. 3, pp. 338–343, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. B. I. Yerevanian, R. J. Koek, J. D. Feusner, S. Hwang, and J. Mintz, “Antidepressants and suicidal behaviour in unipolar depression,” Acta Psychiatrica Scandinavica, vol. 110, no. 6, pp. 452–458, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. J. S. Buyukdura, S. M. McClintock, and P. E. Croarkin, “Psychomotor retardation in depression: biological underpinnings, measurement, and treatment,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 35, no. 2, pp. 395–409, 2011. View at Publisher · View at Google Scholar